Visit our Christmas Gift Finder
Click & Collect from 2 Hours
Last Christmas Delivery Dates
Free UK Standard Delivery on orders £20 and over Order in time for Christmas 18th December 2nd Class | 19th December 1st Class Free Click & Collect to shops From 2 hours of your order*
Chemosensitivity Testing in Oncology - Recent Results in Cancer Research 161 (Paperback)
  • Chemosensitivity Testing in Oncology - Recent Results in Cancer Research 161 (Paperback)
zoom

Chemosensitivity Testing in Oncology - Recent Results in Cancer Research 161 (Paperback)

(editor), (editor)
£201.00
Paperback 245 Pages / Published: 08/10/2012
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary toxic treatment while selecting drugs active in vitro or in the mouse model that might increase the probability of response in the patient. None of these test models, however, achieved routine clinical application in the past. This might be at least in part - lated to large discrepancies that were described between the s- cess rate of the assay systems and the clinical benefit in cancer - tients. The heterogeneity of chemosensitivity that exists between different tumors as well as between individual tumor lesions may be one explanation for these findings. Furthermore, different assay end points such as proliferation, metabolism, and vitality were - veloped to evaluate the effects of cytostatic drugs on tumor cells, and these might be related to the differing results. However, knowledge about procedures for assay-assisted treatment selection has increased rapidly within the past few years, and several studies suggest that test-directed chemotherapy selection now may - prove response rates and survival in various types of tumors. The International Society for Chemosensitivity Testing in - cology (ISCO) was founded to promote, coordinate, and improve clinical and laboratory research in the field of predictive drug te- ing in human tumor cells.

Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN: 9783642624124
Number of pages: 245
Weight: 397 g
Dimensions: 235 x 155 x 14 mm
Edition: Softcover reprint of the original 1st ed. 200

You may also be interested in...

Oxford Handbook of Oncology
Added to basket
£34.99
Part-work (fascículo)
Neuro-Oncology: The Essentials
Added to basket
Practical Radiotherapy Planning
Added to basket
Fast Facts: Skin Cancer
Added to basket
Radical Remission
Added to basket
Cancer Care
Added to basket
£7.99
Paperback
Laws of Medicine
Added to basket
Beat Cancer
Added to basket
£14.99
Paperback
Nursing in Haematological Oncology
Added to basket
Cancer
Added to basket
£12.50
Paperback
The Emperor of All Maladies
Added to basket
The End of Your Life Book Club
Added to basket
Oxford Handbook of Clinical Haematology
Added to basket
£34.99
Part-work (fascículo)

Reviews

Please sign in to write a review

Your review has been submitted successfully.